Institut de Myologie, France

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Nov 5, 2026

Withdrawn

Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study

Nov 4, 2026

Recruiting

Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers

Nov 4, 2026

Recruiting

A Prospective, Longitudinal, Interventional Natural History Study of Children With LAMA2-related Dystrophies

Earlier

Jun 30, 2026TrialVirtual Reality-training in Theory of Mind in the Childhood Form of Myotonic Dystrophy Type 1

Jun 30, 2026TrialFeasibility, Validation and Application of Digital Tools for the Follow-up of Neuromuscular Patient

Jun 30, 2026TrialUltrafast Ultrasound for the Functional Assessment of the Diaphragm: Agreement With Standards Mechanical and Electrophysiological Variables and Diagnosis Performance

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)